Status:
COMPLETED
Assessing the Mother-to-infant Transmission Capabilities of COVID-19 Infection Among Pregnant Women in Ontario, Canada
Lead Sponsor:
Ottawa Hospital Research Institute
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Conditions:
SARS-CoV-2
Covid19
Eligibility:
FEMALE
Brief Summary
In order to assess the mother-to-infant and potential vertical transmission of SARS-CoV-2 infection in pregnant women, maternal and neonatal biological samples were prospectively collected from women ...
Detailed Description
Pregnant individuals with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection were more likely to experience greater disease severity and higher rates of hospitalization, intensive ...
Eligibility Criteria
Inclusion
- Pregnant women with confirmed COVID-19 at any point during pregnancy or suspected COVID-19 at time of delivery (as identified at local hospital) , who will be delivering at a participating hospital in Ontario or Quebec
Exclusion
- None
Key Trial Info
Start Date :
April 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2021
Estimated Enrollment :
246 Patients enrolled
Trial Details
Trial ID
NCT04913948
Start Date
April 30 2020
End Date
July 31 2021
Last Update
April 25 2025
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamilton Health Sciences Corporation
Hamilton, Ontario, Canada, L8L8E7
2
Kingston Health Sciences Centre
Kingston, Ontario, Canada, K7L 2V7
3
Grand River Hospital
Kitchener, Ontario, Canada, N2G1G3
4
London Health Sciences
London, Ontario, Canada, N6A5W9